BioSpace News Archive

Bureau Veritas, a world-leader in testing, inspection, and certification (TIC) services, today announced it has met rigorous ISO 17025 standards to become the first Canadian laboratory to receive accreditation for eDNA testing from the Standards Council of Canada.

DataPath, Inc., a leading provider of technology solutions for healthcare benefits administration, announced today an affiliation with TPA Stream, a middleware software for healthcare and financial services

PER® Global, a worldwide leading resource for continuing medical education (CME), will host the live CME-accredited Medical Crossfire®: Leveraging the Lung Cancer Team in Stage III NSCLC With Immuno-Oncology Strategies, adjunct to the IASLC 2019 World Conference on Lung Cancer.

AmeriHealth Caritas New Hampshire and SolutionHealth announced they have signed a contract that will allow AmeriHealth Caritas New Hampshire members to receive care from SolutionHealth’s hospitals, physicians, and other affiliated providers.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) to add an indication for the treatment of men with metastatic hormone-sensitive prostate cancer (mHSPC).

Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board.

Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) will release its 2019 second quarter financial results sooner than previously announced.

Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors.

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 2019 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, September 4, 2019.

Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced its conference schedule for September 2019.